North America Hemodialysis and Peritoneal Dialysis Market

North America Hemodialysis and Peritoneal Dialysis Market Size (2024 to 2029)

The size of the hemodialysis and peritoneal dialysis market in the North American region is expected to grow USD 42.26 billion by 2029 from USD 30.77 billion in 2024, growing at a CAGR of 6.55% from 2024 to 2029. The market's growth is attributed to an increase in kidney-related disorders and problems since kidney transplantation requires a major operation, a matching donor, and a lifelong immunosuppression treatment regimen. Additionally, there is a growing prevalence of chronic diseases such as obesity, diabetes, and hypertension in North America that is expected to drive growth in the hemodialysis and peritoneal dialysis markets in North America.

Due to its effectiveness and patient-centered approach, home hemodialysis (HHD) is expected to gain popularity among patients in the coming years. With this trend, key companies will implement market strategies such as acquisitions, partnerships, product development, and innovation to drive market growth. Due to the rising number of persons with ESRD and the scarcity of kidneys for transplantation, the market is likely to expand. Kidney function gradually deteriorates as chronic kidney disease (CKD) progresses. Kidney (or renal) illness can develop over time in severe kidney disease (ESRD). This has escalated into a huge public health issue that will only worsen in the future.

Major manufacturers' efforts to produce specialized dialysis equipment and heightened competition among competitors are expected to help drive market expansion. These factors will drive the North American hemodialysis and Peritoneal Dialysis market during the forecast period.

Heart disease and vascular access-related concerns such as bleeding and infection, low blood pressure, nausea, hernia, hepatitis B and C, and anemia are dialysis patients' primary causes of death. Peritonitis is a complication of peritoneal dialysis caused by pathogenic skin germs contaminating the peritoneal dialysate or tubing or by catheter-related diseases. Peritonitis kills 16 percent of Parkinson's disease patients in North America each year (Fresenius Medical Care). As a result, the number of persons who require dialysis is reduced. However, due to the high cost of capital necessary to manufacture and market products and the lengthy regulatory approval procedure, many businesses struggle to prosper and keep up with the growth of the market.

This report on the North American hemodialysis and peritoneal dialysis market has been segmented and sub-segmented into the following categories.

By Type

• Hemodialysis
  • Short-term Catheter
  • Chronic Catheter
  • Graft
  • Fistula
• Peritoneal Dialysis
  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • Automated Peritoneal Dialysis (APD)

By Product

• Device
  • Machine
  • Dialyzer
  • Water treatment system
  • Others
• Consumables
  • Bloodline
  • Concentrates
  • Catheters
  • Others

By End-User

• Home-based
• Hospital-based

By Country

• The United States
• Canada
• Rest of North America

During the forecast period, the North American region is forecasted to lead in the global hemodialysis and peritoneal dialysis market due to factors such as peritoneal dialysis' growing popularity and the growing use of home hemodialysis (HHD) is moving the market ahead. North America is projected to play a significant role in the coming years due to the presence of prominent players. The regional market is growing as patient visits and occurrences of renal failure rise. In addition, hemodialysis machines for home and clinic usage are available in the North American market.

Furthermore, manufacturers concentrate on producing specialized hemodialysis equipment that can handle a wide range of activities. As a result, the end-user experience is projected to suffer. Furthermore, an increase in public healthcare spending, combined with increased awareness campaigns, is likely to propel the hemodialysis market in the North American region forward.

Due to improved healthcare infrastructure and the presence of key market participants, the United States is likely to be the largest market for hemodialysis. According to the Centres for Disease Control and Prevention, chronic kidney disease affects 15% of US adults or 37 million individuals. It is more common in those 65 and older (38%) than in people 45–64 years (13%) or 18–44 years.

KEY MARKET PLAYERS

Companies are playing a notable role in the global hemodialysis and peritoneal dialysis market Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., Nipro Corporation, B Braun Melsungen AG, Nikkiso Co., Ltd., Becton, Dickinson, and Company (C. R. Bard, Inc.), Cook Group, Angiodynamics Inc., Medtronic PLC, and Asahi Kasei Corp.